We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BRTX market cap is 6.35M. The company's latest EPS is USD -3.0625 and P/E is -0.44.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 29k | 4k | 31k | 65k | 31k |
| Operating Income | -4.73M | -4.68M | -5.78M | -3.12M | -3.1M |
| Net Income | -4.66M | -4.35M | -5.68M | -2.98M | -2.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 130k | 77k | 46k | 120k | 146k |
| Operating Income | -8.43M | -2.75M | -26.31M | -18.97M | -15.22M |
| Net Income | -14.65M | -11.27M | -44.3M | -18.49M | -14.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.92M | 16.43M | 14.08M | 13.3M | 13.8M |
| Total Liabilities | 916k | 602k | 594k | 896k | 975k |
| Total Equity | 17M | 15.83M | 13.49M | 12.4M | 12.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.47M | 4.35M | 22.45M | 16.43M | 12.61M |
| Total Liabilities | 14.24M | 5.68M | 857k | 602k | 1.06M |
| Total Equity | -12.78M | -1.33M | 21.6M | 15.83M | 11.55M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.3M | -5.87M | -2.35M | -3.48M | -4.66M |
| Investing | -10.16M | -13.48M | 2.51M | 3.17M | 3.15M |
| Financing | N/A | N/A | N/A | 412k | 2.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.92M | -1.96M | -3.33M | -5.87M | -6.43M |
| Investing | -36k | N/A | -31k | -13.48M | 3.25M |
| Financing | 6.84M | 5.03M | 21.32M | N/A | 2.35M |
| Market Cap | 6.35M |
| Price to Earnings Ratio | -0.44 |
| Price to Sales Ratio | 43.87 |
| Price to Cash Ratio | 7.24 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 4.71M |
| Average Volume (1 week) | 3.68M |
| Average Volume (1 Month) | 1.55M |
| 52 Week Change | -66.91% |
| 52 Week High | 7.13 |
| 52 Week Low | 1.20 |
| Spread (Intraday) | 0.06 (4.35%) |
| Company Name | BioRestorative Therapies Inc |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.biorestorative.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
